Sign in
Phentolamine Ophthalmic Solution Rapidly Reverses Pharmacologically Induced Mydriasis in Two Pivotal Phase 3 MIRA Trials
David S. Boyer, MD
Updates from the Field
2022
Longitudinal Results of a Prospective SDOCT Imaging Study of Sickle Cell Eyes
Jennifer I. Lim, MD, FARVO, FASRS
Annual Meeting Talks
2019
Integrin Antagonism for DME
Hugo Quiroz-Mercado, MD
Category: Risk Management